https://pepite-depot.univ-lille.fr/RESTREINT/Th_Medecine/2023/2023ULILM132.pdf 2023 France dissertations, academic dissertations, academic Additional Surgery for New Tumor Event Present Additional Surgery for New Tumor Event Present Adjuvant Post-operative Immunological Therapy Was Administered Adjuvant Post-operative Immunological Therapy Was Administered KIT Mutation Analysis Was Performed KIT Mutation Analysis Was Performed Metastatic Diagnosis Present Question Metastatic Diagnosis Present Question NF1 Mutation Analysis Was Performed NF1 Mutation Analysis Was Performed Cancer History Present Cancer History Present IDH Gene Family Mutation IDH Gene Family Mutation Adjuvant Post-operative Radiation Therapy Was Administered Adjuvant Post-operative Radiation Therapy Was Administered Adjuvant Post-operative Targeted Molecular Therapy Was Administered Adjuvant Post-operative Targeted Molecular Therapy Was Administered Chief Complaint Caused by Trauma Chief Complaint Caused by Trauma Adjuvant Post-operative Chemotherapy Was Administered Adjuvant Post-operative Chemotherapy Was Administered ATRX Gene Mutation ATRX Gene Mutation Interferon Gamma Treatment was Administered Prior to Specimen Resection Interferon Gamma Treatment was Administered Prior to Specimen Resection Patient was Previously Evaluated for Current Chief Complaint Patient was Previously Evaluated for Current Chief Complaint Minor Criteria for Rheumatic Heart Disease Present Minor Criteria for Rheumatic Heart Disease Present Adjuvant I-131 Therapy Positive Adjuvant I-131 Therapy Positive Use of Smokeless Tobacco at Time of Diagnosis Positive Use of Smokeless Tobacco at Time of Diagnosis Positive Intervention Given for Kawasaki Disease Intervention Given for Kawasaki Disease Immunotherapy Was Administered as an Additional Treatment for a New Tumor Event Immunotherapy Was Administered as an Additional Treatment for a New Tumor Event Documentation Present Documentation Present History of Colorectal Cancer Positive History of Colorectal Cancer Positive Has Sibling Has Sibling Adjuvant Post-operative Pharmaceutical Therapy Was Administered Adjuvant Post-operative Pharmaceutical Therapy Was Administered Family History of Stomach Cancer Present Family History of Stomach Cancer Present Interferon Gamma Treatment was Administered 90 Days Prior to Specimen Resection Interferon Gamma Treatment was Administered 90 Days Prior to Specimen Resection EGFR Mutation Analysis Was Performed EGFR Mutation Analysis Was Performed Intercurrent Illness is Present at Onset of Chief Complaint Intercurrent Illness is Present at Onset of Chief Complaint Preoperative IV Opiates were Administered Preoperative IV Opiates were Administered ROS1 Rearrangement Analysis Was Performed ROS1 Rearrangement Analysis Was Performed Hormone Therapy Was Administered as an Additional Treatment for a New Tumor Event Hormone Therapy Was Administered as an Additional Treatment for a New Tumor Event Has Response to Intervention for Kawasaki Disease Has Response to Intervention for Kawasaki Disease First Degree Family History of Primary Brain Tumor Positive First Degree Family History of Primary Brain Tumor Positive Radiation Was Administered as an Additional Treatment for a New Tumor Event Radiation Was Administered as an Additional Treatment for a New Tumor Event Medication Taken Medication Taken Trial Phase Trial Phase spirituality spirituality KRAS Mutation Analysis Was Performed KRAS Mutation Analysis Was Performed Known History of Congenital Heart Disease Known History of Congenital Heart Disease Hypertension Present Hypertension Present Tumor Progression Present After Initial Treatment Tumor Progression Present After Initial Treatment Lymph Node Dissection Was Performed Lymph Node Dissection Was Performed Therapeutic Ionizing Radiation to Head History Present Therapeutic Ionizing Radiation to Head History Present Peripheral Blood Immunophenotyping and Cytochemistry Were Performed Peripheral Blood Immunophenotyping and Cytochemistry Were Performed First Degree Family History Thyroid Cancer Positive First Degree Family History Thyroid Cancer Positive Lost To Follow-Up Lost To Follow-Up Speak Speak EGFR Gene Amplification EGFR Gene Amplification PTEN Gene Mutation PTEN Gene Mutation IDH Family Mutation Analysis Was Performed IDH Family Mutation Analysis Was Performed Radiation History Positive Radiation History Positive Preoperative IV Sedation was Administered Preoperative IV Sedation was Administered Chemotherapy Was Administered as an Additional Treatment for a New Tumor Event Chemotherapy Was Administered as an Additional Treatment for a New Tumor Event Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Performed Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Performed RET Rearrangement Analysis Was Performed RET Rearrangement Analysis Was Performed Preoperative IV Antacids were Administered Preoperative IV Antacids were Administered MET Mutation Analysis Was Performed MET Mutation Analysis Was Performed New Disease is Multifocal New Disease is Multifocal Chemotherapy Received Chemotherapy Received ERBB2 Mutation Analysis Was Performed ERBB2 Mutation Analysis Was Performed History of Medical Treatment Present History of Medical Treatment Present Multiple Known Primary Tumors Present at Initial Melanoma Diagnosis Multiple Known Primary Tumors Present at Initial Melanoma Diagnosis Patient was Postmenopausal with no Prior Oophorectomy Patient was Postmenopausal with no Prior Oophorectomy PDGFRA Mutation Analysis Was Performed PDGFRA Mutation Analysis Was Performed First Degree Family History Cancer Positive First Degree Family History Cancer Positive Additional Surgery for New Loco-Regional Tumor Event Was Performed Additional Surgery for New Loco-Regional Tumor Event Was Performed Known History of Gestational Complication Known History of Gestational Complication Fluorescence In Situ Hybridization Was Performed Fluorescence In Situ Hybridization Was Performed 10q23/PTEN Locus Deletion Analysis Was Performed 10q23/PTEN Locus Deletion Analysis Was Performed Additional Molecular Studies Were Performed Additional Molecular Studies Were Performed Another Form of Birth Control was Used Another Form of Birth Control was Used EGFR Amplification Analysis Was Performed EGFR Amplification Analysis Was Performed Known History of Rheumatic Fever Known History of Rheumatic Fever Other Preoperative IV Medications were Administered Other Preoperative IV Medications were Administered Physician Diagnosed Diabetes Present Physician Diagnosed Diabetes Present Routine Cytogenetics Were Completed Routine Cytogenetics Were Completed ALK Rearrangement Analysis Was Performed ALK Rearrangement Analysis Was Performed NRAS Mutation Analysis Was Performed NRAS Mutation Analysis Was Performed Tumor Reoccurrence Present After Initial Treatment Tumor Reoccurrence Present After Initial Treatment Evidence of Disease Present after Completion of Therapy Evidence of Disease Present after Completion of Therapy Chemical/Occupational Exposure Present Chemical/Occupational Exposure Present BRAF Rearrangement Analysis Was Performed BRAF Rearrangement Analysis Was Performed Regular Smokeless Tobacco Use for Six Weeks or More Positive Regular Smokeless Tobacco Use for Six Weeks or More Positive Preoperative IV Antiemetics were Administered Preoperative IV Antiemetics were Administered Additional Surgery for New Metastatic Tumor Event Was Performed Additional Surgery for New Metastatic Tumor Event Was Performed BRAF Mutation Analysis Was Performed BRAF Mutation Analysis Was Performed Regional Anesthesia was Administered Regional Anesthesia was Administered 1p/19q Deletion Analysis Was Performed 1p/19q Deletion Analysis Was Performed What Month is it Question What Month is it Question IV Anesthesia was Administered IV Anesthesia was Administered YES1 wt Allele YES1 wt Allele Targeted Molecular Therapy Was Administered as an Additional Treatment for a New Tumor
Event Targeted Molecular Therapy Was Administered as an Additional Treatment for a New Tumor
Event ATRX Mutation Analysis Was Performed ATRX Mutation Analysis Was Performed Known History of Illicit Drug Use Known History of Illicit Drug Use New Tumor Event After Initial Treatment Present New Tumor Event After Initial Treatment Present SDH Complex Mutation Analysis Was Performed SDH Complex Mutation Analysis Was Performed Known History of Kawasaki Disease Known History of Kawasaki Disease PTEN Mutation Analysis Was Performed PTEN Mutation Analysis Was Performed TP53 Mutation Analysis Was Performed TP53 Mutation Analysis Was Performed Subsequent Known Primary Melanoma(s) Found During the Follow-Up Subsequent Known Primary Melanoma(s) Found During the Follow-Up Known History of Neonatal Complication Known History of Neonatal Complication Local Anesthesia Agents were Administered Local Anesthesia Agents were Administered Additional Immunohistochemistry Was Performed Additional Immunohistochemistry Was Performed Participant Exposed to Secondhand Smoke Participant Exposed to Secondhand Smoke Known History of Alcohol Use Known History of Alcohol Use MGMT Promoter Methylation Testing Was Performed MGMT Promoter Methylation Testing Was Performed
Automatic exact mappings (from CISMeF team)